Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| Dir | GORMAN KEVIN CHARLES | 620.9K | $85.66M | - |
| CEO | Gano Kyle | 140.4K | $19.37M | - |
| Dir | | 120.5K | $16.62M | - |
| Dir | RASTETTER WILLIAM H | 58.4K | $8.05M | - |
| Other | | 47.8K | $6.59M | - |
Transactions
50 transactions · page 8
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2021-02-08 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 2,626 | $116.02 | $304,669.99 | -1.0% | → |
| 2021-02-08 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 12,888 | $116.26 | $1,498,368.03 | -0.7% | → |
| 2021-02-08 | Lippoldt Darin | Chief Legal Officer | Sale+OE | 4,012 | $116.32 | $466,676.85 | -3.0% | → |
| 2021-02-08 | Gano Kyle | Chief Business Development Off | Sell | 6,370 | $115.65 | $736,702.16 | -1.2% | → |
| 2021-02-08 | Bozigian Haig P. | Chief Development Officer | Sell | 4,546 | $116.33 | $528,857.09 | -0.7% | → |
| 2021-02-08 | BENEVICH ERIC | Chief Commercial Officer | Sell | 5,079 | $116.38 | $591,088.69 | -6.4% | → |
| 2021-02-05 | Cooke Julie | Chief Human Resources Officer | Sell | 605 | $113.86 | $68,886.21 | -4.8% | → |
| 2021-02-05 | Lloyd-Smith Malcolm | Chief Regulatory Officer | Sell | 865 | $114.15 | $98,739.23 | -2.8% | → |
| 2021-01-26 | Lloyd-Smith Malcolm | Chief Regulatory Officer | Sale+OE | 18,670 | $119.97 | $2,239,777.48 | -11.4% | → |
| 2021-01-26 | BENEVICH ERIC | Chief Commercial Officer | Sale+OE | 5,477 | $120.02 | $657,371.27 | -7.8% | → |
| 2021-01-26 | LYONS GARY A | Director | Sell | 2,000 | $120.02 | $240,046.56 | -0.4% | → |
| 2021-01-08 | ROBERTS EIRY | Chief Medical Officer | Sell | 2,632 | $111.06 | $292,297.29 | -14.2% | → |
| 2021-01-08 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sale+OE | 308,250 | $110.22 | $33,973,876.51 | -25.9% | → |
| 2020-12-01 | ABERNETHY MATT | Chief Financial Officer | Sell | 1,645 | $94.66 | $155,720.96 | -12.5% | → |
| 2020-11-12 | BENEVICH ERIC | Chief Commercial Officer | Sell | 2,257 | $90.71 | $204,722.99 | -11.5% | → |
| 2020-11-12 | ROBERTS EIRY | Chief Medical Officer | Sell | 2,257 | $90.74 | $204,809.89 | -14.3% | → |
| 2020-11-12 | Lloyd-Smith Malcolm | Chief Regulatory Officer | Sell | 2,257 | $90.73 | $204,775.80 | -7.2% | → |
| 2020-11-12 | Lippoldt Darin | Chief Legal Officer | Sell | 2,257 | $90.72 | $204,754.59 | -7.0% | → |
| 2020-11-12 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 2,257 | $90.73 | $204,783.70 | -2.7% | → |
| 2020-11-12 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 3,390 | $90.78 | $307,747.59 | -0.8% | → |
| 2020-11-12 | Gano Kyle | Chief Business Development Off | Sell | 2,257 | $90.73 | $204,770.39 | -2.3% | → |
| 2020-11-12 | Cooke Julie | Chief Human Resources Officer | Sell | 2,257 | $90.73 | $204,777.61 | -16.3% | → |
| 2020-11-12 | Bozigian Haig P. | Chief Development Officer | Sell | 2,257 | $90.74 | $204,806.50 | -1.5% | → |